Skin News and Research

RSS

New study highlights risks of anti-ERBB2 cancer drugs during pregnancy

Study finds that anti-ERBB2 inhibitors used in breast cancer treatment pose significant risks to pregnancy and fetal health, including higher likelihoods of congenital defects and intrauterine growth restriction. Researchers recommend careful monitoring and possibly discontinuing these drugs during pregnancy despite their effectiveness against cancer.

29 Oct 2023

Listening to favorite music has a larger effect on acute thermal pain reduction

Even before it was found to reduce pain and anxiety in modern times, music has been used for centuries to relieve pain. Now, researchers in Canada have investigated which aspects of listening to music can lead to a decreased pain perception.

28 Oct 2023

Imperial researchers discover hidden mechanism behind feeling touch

Imperial researchers have discovered a hidden mechanism within hair follicles that allow us to feel touch.

27 Oct 2023

Low-cost anti-inflammatory hydrogel could help treat chronic skin lesions in people with diabetes

Researchers in São Paulo state, Brazil, have developed a low-cost anti-inflammatory hydrogel that in future could help treat chronic skin lesions such as those often seen in people with diabetes.

27 Oct 2023

Study highlights a “sunscreen paradox” and the false sense of security against skin cancer

Sunscreen usage is climbing, but so are melanoma and skin cancer rates: this, researchers say, is the sunscreen paradox.

27 Oct 2023

Moderate wine consumption may reduce the risk of some cancers

A meta-analysis published in Frontiers in Nutrition finds no link between moderate wine consumption and increased cancer risk; instead, it suggests that wine may have protective effects against certain types of tumors. Further research is needed to confirm these findings and understand the mechanisms involved.

26 Oct 2023

Groundbreaking research advances understanding of how pathogens impact cancer

Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why.

26 Oct 2023

Somatic mutations in the skin not responsible for the start or spread of psoriasis

Psoriasis - a chronic skin condition - is not caused or spread by spontaneous genetic mutations in the skin, new research suggests.

26 Oct 2023

Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

When targeting problem proteins involved in causing or spreading disease, a drug will often clog up a protein's active site so it can't function and wreak havoc.

25 Oct 2023

How strep bacteria outsmart your immune system and why it matters for treatment

Researchers discover that Group A streptococcal infections alter immunoglobulin G (IgG) homeostasis to evade the immune system, affecting the transition from local to systemic infections. The study also raises concerns about the effectiveness of antibody-based therapies, as the bacteria's virulence factors can degrade therapeutic antibodies.

25 Oct 2023

New smartphone attachment could enable low-cost neurological screening for all

Engineers at the University of California San Diego have developed a smartphone attachment that could enable people to screen for a variety of neurological conditions, such as Alzheimer's disease and traumatic brain injury, at low cost - and do so accurately regardless of their skin tone.

25 Oct 2023

Mapping the mysteries: Study reveals surprising hubs of human immune cells

Researchers in Israel comprehensively mapped the distribution and mass of primary immune cells across human tissues. This groundbreaking study, using advanced biotechnological methods, provides insights into the immune system's cellular network, challenging existing notions and emphasizing the bone marrow, lymph nodes, and spleen as primary immune cell reservoirs.

24 Oct 2023

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

A recent study in "Microorganisms" delves into the relationship between the microbiome and biliary tract cancer, revealing distinct microbial compositions in patients compared to healthy individuals. This research highlights potential diagnostic biomarkers and suggests that altering gut microbial composition might enhance responses to cancer immunotherapy.

24 Oct 2023

Ketogenic diet boosts IVF success for women with PCOS, study reveals

A recent study in the journal "Nutrients" investigated the effects of dietary interventions, including the Mediterranean diet (MD) and a very low-calorie ketogenic diet (VLCKD), on overweight or obese women with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF).

24 Oct 2023

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

Researchers from The Hospital for Sick Children (SickKids), the Ontario Institute for Cancer Research (OICR) and University Health Network (UHN) have demonstrated that by analyzing patients' blood samples, they are able to detect cancer earlier in individuals with Li-Fraumeni syndrome, an inherited condition with an almost 100 percent life-time risk of developing cancer.

24 Oct 2023

AI-assisted smartphone app performs well in skin cancer diagnosis

Artificial intelligence (AI) is already widely used in medical diagnostics. An Austrian-Australian research team led by dermatologist Harald Kittler from MedUni Vienna investigated the extent to which diagnosis and therapy of pigmented skin lesions benefit from it in a realistic clinical scenario.

24 Oct 2023

Study reveals unexpected role of pulmonary ionocytes in lung function

A new study by University of Iowa researchers finds that rare lung cells known as pulmonary ionocytes facilitate the absorption of water and salt from the airway surface.

24 Oct 2023

New insights into the molecular basis of schizophrenia during early brain development

Schizophrenia is a severe neuropsychiatric disease that remains poorly understood and treated.

24 Oct 2023

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more than half of surgical specimens taken from patients who had been treated with neoadjuvant (pre-operative) pembrolizumab.

24 Oct 2023

Large language models perpetuate racial bias in healthcare

The tendency of four commercial LLMs to perpetuate race-based medical misconceptions.

24 Oct 2023

Skin News and Research

New study highlights risks of anti-ERBB2 cancer drugs during pregnancy

Listening to favorite music has a larger effect on acute thermal pain reduction

Imperial researchers discover hidden mechanism behind feeling touch

Low-cost anti-inflammatory hydrogel could help treat chronic skin lesions in people with diabetes

Study highlights a “sunscreen paradox” and the false sense of security against skin cancer

Moderate wine consumption may reduce the risk of some cancers

Groundbreaking research advances understanding of how pathogens impact cancer

Somatic mutations in the skin not responsible for the start or spread of psoriasis

Stanford chemists uncover new pathway for protein degradation, opening door to new therapeutics

How strep bacteria outsmart your immune system and why it matters for treatment

New smartphone attachment could enable low-cost neurological screening for all

Mapping the mysteries: Study reveals surprising hubs of human immune cells

Could the microbiome hold the key to diagnosing and treating biliary tract cancer?

Ketogenic diet boosts IVF success for women with PCOS, study reveals

Blood test detects cancer earlier in individuals with Li-Fraumeni syndrome

AI-assisted smartphone app performs well in skin cancer diagnosis

Study reveals unexpected role of pulmonary ionocytes in lung function

New insights into the molecular basis of schizophrenia during early brain development

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

Large language models perpetuate racial bias in healthcare

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News